DCF — NORTHWEST MEDICAL CENTER
Enterprise Value: $-102.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-102.4M
Enterprise Value
$-41.3M
PV of Cash Flows
$-61.1M
PV of Terminal Value
$-98.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $327.9M | $-1.5M | -0.0% | $-15.4M | $-14.0M |
| Year 2 | $337.7M | $1.8M | 1.0% | $-12.5M | $-10.3M |
| Year 3 | $347.8M | $5.3M | 2.0% | $-9.4M | $-7.1M |
| Year 4 | $358.3M | $7.3M | 2.0% | $-7.9M | $-5.4M |
| Year 5 | $369.0M | $8.4M | 2.0% | $-7.2M | $-4.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-102.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$318.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.009684112345773916
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5